Blood Research · 2018 · 15 citations · 14 references
MedicineHematologyOncologyChemotherapyHematologic OncologyStem Cell TransplantationConditioning RegimensHematopoietic Stem Cell TransplantationHigh-dose ChemotherapyMultiple MyelomaAutologous Stem Cell TherapyAutologous Transplant ConditioningMelphalan ConditioningMelphalan-based ConditioningMultiple Myeloma ChemotherapyMultiple Myeloma TherapyMultiple Myeloma TreatmentTransplantation For Hematologic Malignancies
BACKGROUND: High-dose melphalan (HDMEL) represents the standard conditioning regimen before autologous stem cell transplant (ASCT) in multiple myeloma (MM), but recent updates have suggested combination of melphalan with bulsulfan (BUMEL) is also associated with favorable outcomes. We performed the current study to address the lack of comparative studies between the two conditioning regimens in Asian populations. METHODS: Using the Korean National Health Insurance and Korean Health Insurance Review and Assessment Service databases, 1,304 patients newly diagnosed with MM undergoing ASCT between January 2010 and December 2014 were identified. Patients were divided according to conditioning regimen (HDMEL vs. BUMEL), and after case matching, 428 patients undergoing HDMEL conditioning were compared to 107 patients undergoing BUMEL conditioning with respect to clinical course and treatment outcomes. RESULTS: =0.525), respectively. Although not statistically significant, BUMEL conditioning was associated with more platelet transfusion, while HDMEL was associated with more granulocyte colony stimulating factor support. In multivariate analysis, BUMEL conditioning was not inferior to HDMEL conditioning in regard to both PFS and OS. CONCLUSION: Our study confirmed that BUMEL is an effective and well-tolerated alternative to HDMEL conditioning, with better PFS.
14
Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma
Michel Attal, Valérie Lauwers‐Cancès, Gérald Marit et al. · New England Journal of Medicine · 2012 · 1.2K citations · Full text
Medicine, Oncology, Pharmacotherapy +13
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
Philip L. McCarthy, Kouros Owzar, Craig C. Hofmeister et al. · New England Journal of Medicine · 2012 · 1.1K citations · Full text
Autologous Transplantation and Maintenance Therapy in Multiple Myeloma
Antonio Palumbo, Federica Cavallo, Francesca Gay et al. · New England Journal of Medicine · 2014 · 781 citations · Full text
Medicine, Oncology, Pharmacotherapy +14
Philippe Moreau · Blood · 2002 · 566 citations · Full text
Medicine, Hematology, Oncology +17
Francesca Gay, Stefania Oliva, Maria Teresa Petrucci et al. · The Lancet Oncology · 2015 · 313 citations · Full text
Medicine, Oncology, Pharmacotherapy +17